 |
인쇄하기
취소
|
Lilly to launch anti-osteoporosis drug, Fosteo.
Lilly Korea announced to launch Fosteo (teriparatide), a unique anti-osteoporosisdrug, for the promotion of bone formation.
Fosteo is a parathyroidal hormone to promote a bone formation instead of blocking an excretion of bone components from the body as shown by other drugs already on the markets such as the bisphosphonates.
Lilly Korea said that Fosteo showed a significant effect in th...
Fosteo is a parathyroidal hormone to promote a bone formation instead of blocking an excretion of bone components from the body as shown by other drugs already on the markets such as the bisphosphonates.
Lilly Korea said that Fosteo showed a significant effect in th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.